Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders
- PMID: 11753429
- DOI: 10.1038/nsb732
Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders
Abstract
Monoamine oxidase B (MAO B) is a mitochondrial outermembrane flavoenzyme that is a well-known target for antidepressant and neuroprotective drugs. We determined the structure of the human enzyme to 3 A resolution. The enzyme binds to the membrane through a C-terminal transmembrane helix and apolar loops located at various positions in the sequence. The electron density shows that pargyline, an analog of the clinically used MAO B inhibitor, deprenyl, binds covalently to the flavin N5 atom. The active site of MAO B consists of a 420 A(3)-hydrophobic substrate cavity interconnected to an entrance cavity of 290 A(3). The recognition site for the substrate amino group is an aromatic cage formed by Tyr 398 and Tyr 435. The structure provides a framework for probing the catalytic mechanism, understanding the differences between the B- and A-monoamine oxidase isoforms and designing specific inhibitors.
Similar articles
-
Crystal structure of human monoamine oxidase B, a drug target enzyme monotopically inserted into the mitochondrial outer membrane.FEBS Lett. 2004 Apr 30;564(3):225-8. doi: 10.1016/S0014-5793(04)00209-1. FEBS Lett. 2004. PMID: 15111100 Review.
-
Structure of the human mitochondrial monoamine oxidase B: new chemical implications for neuroprotectant drug design.Neurology. 2006 Oct 10;67(7 Suppl 2):S5-7. doi: 10.1212/wnl.67.7_suppl_2.s5. Neurology. 2006. PMID: 17030739
-
Structure of rat monoamine oxidase A and its specific recognitions for substrates and inhibitors.J Mol Biol. 2004 Apr 16;338(1):103-14. doi: 10.1016/j.jmb.2004.02.032. J Mol Biol. 2004. PMID: 15050826
-
Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.Bioorg Med Chem. 2009 Sep 15;17(18):6761-72. doi: 10.1016/j.bmc.2009.07.033. Epub 2009 Jul 23. Bioorg Med Chem. 2009. PMID: 19682910
-
[Use of selective inhibitors for computer modeling of the monoamine oxidase active site].Vopr Med Khim. 1997 Nov-Dec;43(6):527-36. Vopr Med Khim. 1997. PMID: 9503570 Review. Russian.
Cited by
-
Molecular basis of inhibitory activities of berberine against pathogenic enzymes in Alzheimer's disease.ScientificWorldJournal. 2012;2012:823201. doi: 10.1100/2012/823201. Epub 2012 Jan 4. ScientificWorldJournal. 2012. PMID: 22262957 Free PMC article.
-
In silico studies of natural product-like caffeine derivatives as potential MAO-B inhibitors/AA2AR antagonists for the treatment of Parkinson's disease.J Integr Bioinform. 2022 Sep 19;19(4):20210027. doi: 10.1515/jib-2021-0027. eCollection 2022 Dec 1. J Integr Bioinform. 2022. PMID: 36112816 Free PMC article.
-
Positive selection in MAOA gene is human exclusive: determination of the putative amino acid change selected in the human lineage.Hum Genet. 2004 Oct;115(5):377-86. doi: 10.1007/s00439-004-1179-6. Epub 2004 Sep 3. Hum Genet. 2004. PMID: 15349769
-
Molecular docking/dynamics simulations, MEP analysis, bioisosteric replacement and ADME/T prediction for identification of dual targets inhibitors of Parkinson's disease with novel scaffold.In Silico Pharmacol. 2023 Jan 19;11(1):3. doi: 10.1007/s40203-023-00139-3. eCollection 2023. In Silico Pharmacol. 2023. PMID: 36687301 Free PMC article.
-
The aromatic cage in the active site of monoamine oxidase B: effect on the structural and electronic properties of bound benzylamine and p-nitrobenzylamine.J Neural Transm (Vienna). 2007;114(6):693-8. doi: 10.1007/s00702-007-0670-3. Epub 2007 Mar 31. J Neural Transm (Vienna). 2007. PMID: 17401536
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Other Literature Sources
Medical
Molecular Biology Databases